Effect of Ketorolac on Pharmacokinetics and Pharmacodynamics of 5-Fluorouracil: In Vivo and In Vitro Study

Background. This study aimed to evaluate the impact of ketorolac on the pharmacokinetics of 5-FU and its effect on the efficacy of 5-fluorouracil (5-FU) on the HT-29 cell line. Methods. Cell culture: the HT-29 cell line was treated with different concentrations of 5-FU, ketorolac, and combination of...

Full description

Saved in:
Bibliographic Details
Main Authors: Motahare Atefinezhad, Ahmadreza Moghadamnia, Seyed Parsa Eftekhar, Ali Akbar Moghadamnia, Sohrab Kazemi
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Journal of Tropical Medicine
Online Access:http://dx.doi.org/10.1155/2022/5267861
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849435364340531200
author Motahare Atefinezhad
Ahmadreza Moghadamnia
Seyed Parsa Eftekhar
Ali Akbar Moghadamnia
Sohrab Kazemi
author_facet Motahare Atefinezhad
Ahmadreza Moghadamnia
Seyed Parsa Eftekhar
Ali Akbar Moghadamnia
Sohrab Kazemi
author_sort Motahare Atefinezhad
collection DOAJ
description Background. This study aimed to evaluate the impact of ketorolac on the pharmacokinetics of 5-FU and its effect on the efficacy of 5-fluorouracil (5-FU) on the HT-29 cell line. Methods. Cell culture: the HT-29 cell line was treated with different concentrations of 5-FU, ketorolac, and combination of 5-FU and ketorolac for 24 and 48 hours. The cell viability (%) was calculated by the MTT assay. Animal study: rats were randomly divided into control and pretreatment groups. The control group received physiological saline, whereas the pretreatment group received ketorolac by intraperitoneal (i.p.) injections on a daily basis for 14 days. On the 15th day, both groups received 5-FU (i.p.). Blood samples were collected at different times for HPLC analysis, and 5-FU pharmacokinetic parameters were calculated. Results. At cell culture study, in a certain concentration range, combination therapy showed synergistic effects (<0.05). However, at concentrations above this range, combination therapy showed antagonistic effects on 5-FU efficacy (<0.05). According to the pharmacokinetic analysis, pretreatment with ketorolac resulted in a significant increase in AUC, Cmax, and Tmax of 5-FU (<0.05) and a significant decrease in V/F and Cl/F of 5-FU (<0.05). Conclusions. Combination therapy with ketorolac and 5-FU, depending on time and concentration, has a synergistic effect on reducing the viability of cancer cells. Also, ketorolac is able to alter the pharmacokinetics of 5-FU. Since there is a close relationship between pharmacokinetic parameters of 5-FU and its effectiveness/toxicity, it seems that these changes are towards creating a synergistic effect on 5-FU cytotoxicity. These results suggest the need to optimize the dose of these drugs in order to increase clinical efficacy and reduce the toxicity associated with them.
format Article
id doaj-art-e57d7ad06d754592835e7a8dc8dce01c
institution Kabale University
issn 1687-9694
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series Journal of Tropical Medicine
spelling doaj-art-e57d7ad06d754592835e7a8dc8dce01c2025-08-20T03:26:20ZengWileyJournal of Tropical Medicine1687-96942022-01-01202210.1155/2022/5267861Effect of Ketorolac on Pharmacokinetics and Pharmacodynamics of 5-Fluorouracil: In Vivo and In Vitro StudyMotahare Atefinezhad0Ahmadreza Moghadamnia1Seyed Parsa Eftekhar2Ali Akbar Moghadamnia3Sohrab Kazemi4Department of PharmacologyStudent Research CommitteeDepartment of Pharmacology and ToxicologyDepartment of Pharmacology and ToxicologyCellular and Molecular Biology Research CenterBackground. This study aimed to evaluate the impact of ketorolac on the pharmacokinetics of 5-FU and its effect on the efficacy of 5-fluorouracil (5-FU) on the HT-29 cell line. Methods. Cell culture: the HT-29 cell line was treated with different concentrations of 5-FU, ketorolac, and combination of 5-FU and ketorolac for 24 and 48 hours. The cell viability (%) was calculated by the MTT assay. Animal study: rats were randomly divided into control and pretreatment groups. The control group received physiological saline, whereas the pretreatment group received ketorolac by intraperitoneal (i.p.) injections on a daily basis for 14 days. On the 15th day, both groups received 5-FU (i.p.). Blood samples were collected at different times for HPLC analysis, and 5-FU pharmacokinetic parameters were calculated. Results. At cell culture study, in a certain concentration range, combination therapy showed synergistic effects (<0.05). However, at concentrations above this range, combination therapy showed antagonistic effects on 5-FU efficacy (<0.05). According to the pharmacokinetic analysis, pretreatment with ketorolac resulted in a significant increase in AUC, Cmax, and Tmax of 5-FU (<0.05) and a significant decrease in V/F and Cl/F of 5-FU (<0.05). Conclusions. Combination therapy with ketorolac and 5-FU, depending on time and concentration, has a synergistic effect on reducing the viability of cancer cells. Also, ketorolac is able to alter the pharmacokinetics of 5-FU. Since there is a close relationship between pharmacokinetic parameters of 5-FU and its effectiveness/toxicity, it seems that these changes are towards creating a synergistic effect on 5-FU cytotoxicity. These results suggest the need to optimize the dose of these drugs in order to increase clinical efficacy and reduce the toxicity associated with them.http://dx.doi.org/10.1155/2022/5267861
spellingShingle Motahare Atefinezhad
Ahmadreza Moghadamnia
Seyed Parsa Eftekhar
Ali Akbar Moghadamnia
Sohrab Kazemi
Effect of Ketorolac on Pharmacokinetics and Pharmacodynamics of 5-Fluorouracil: In Vivo and In Vitro Study
Journal of Tropical Medicine
title Effect of Ketorolac on Pharmacokinetics and Pharmacodynamics of 5-Fluorouracil: In Vivo and In Vitro Study
title_full Effect of Ketorolac on Pharmacokinetics and Pharmacodynamics of 5-Fluorouracil: In Vivo and In Vitro Study
title_fullStr Effect of Ketorolac on Pharmacokinetics and Pharmacodynamics of 5-Fluorouracil: In Vivo and In Vitro Study
title_full_unstemmed Effect of Ketorolac on Pharmacokinetics and Pharmacodynamics of 5-Fluorouracil: In Vivo and In Vitro Study
title_short Effect of Ketorolac on Pharmacokinetics and Pharmacodynamics of 5-Fluorouracil: In Vivo and In Vitro Study
title_sort effect of ketorolac on pharmacokinetics and pharmacodynamics of 5 fluorouracil in vivo and in vitro study
url http://dx.doi.org/10.1155/2022/5267861
work_keys_str_mv AT motahareatefinezhad effectofketorolaconpharmacokineticsandpharmacodynamicsof5fluorouracilinvivoandinvitrostudy
AT ahmadrezamoghadamnia effectofketorolaconpharmacokineticsandpharmacodynamicsof5fluorouracilinvivoandinvitrostudy
AT seyedparsaeftekhar effectofketorolaconpharmacokineticsandpharmacodynamicsof5fluorouracilinvivoandinvitrostudy
AT aliakbarmoghadamnia effectofketorolaconpharmacokineticsandpharmacodynamicsof5fluorouracilinvivoandinvitrostudy
AT sohrabkazemi effectofketorolaconpharmacokineticsandpharmacodynamicsof5fluorouracilinvivoandinvitrostudy